1. Relations between approved platinum drugs and non-coding RNAs in mesothelioma
    Bernhard Biersack, 2018, Non-coding RNA Research CrossRef
  2. miR‑3120‑5p acts as a diagnostic biomarker in non‑small cell lung cancer and promotes cancer cell proliferation and invasion by targeting KLF4
    Hongwei Xu et al, 2018, Molecular Medicine Reports CrossRef
  3. Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators
    Milad Ashrafizadeh et al, 2021, Cellular Signalling CrossRef
  4. Retraction: Long Noncoding RNA RGMB-AS1 Indicates a Poor Prognosis and Modulates Cell Proliferation, Migration and Invasion in Lung Adenocarcinoma
    null null, 2021, PLOS ONE CrossRef
  5. The Significance of MicroRNAs Expression in Regulation of Extracellular Matrix and Other Drug Resistant Genes in Drug Resistant Ovarian Cancer Cell Lines
    Dominika Kazmierczak et al, 2020, International Journal of Molecular Sciences CrossRef
  6. miR-340 alleviates chemoresistance of osteosarcoma cells by targeting ZEB1
    Haibin Yan et al, 2018, Anti-Cancer Drugs CrossRef
  7. Knockdown of microRNA-203 reduces cisplatin chemo-sensitivity to osteosarcoma cell lines MG63 and U2OS in vitro by targeting RUNX2
    Zhengxiang Huang et al, 2021, Journal of Chemotherapy CrossRef
  8. Emerging roles of microRNAs as a regulator in the progression of lung cancer and their implications in its diagnosis and therapy
    Surya Kant Tripathi et al, 2019, AGO-Driven Non-Coding RNAs CrossRef
  9. MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition
    Qianqian Shao et al, 2018, Gene CrossRef
  10. Current updates on microRNAs as regulators of chemoresistance
    Metin Çalışkan et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  11. Interplay of non-coding RNAs and approved antimetabolites such as gemcitabine and pemetrexed in mesothelioma
    Bernhard Biersack, 2018, Non-coding RNA Research CrossRef